• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在加拿大cPRA计算器中,cPRA随DQA、DPA和DPB不可接受抗原增加而升高。

cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.

作者信息

Tinckam K J, Liwski R, Pochinco D, Mousseau M, Grattan A, Nickerson P, Campbell P

机构信息

Division of Nephrology, Department of Medicine and HLA Laboratory, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Canadian Blood Services, Organ and Tissue Donation and Transplantation, Ottawa, Ontario, Canada.

出版信息

Am J Transplant. 2015 Dec;15(12):3194-201. doi: 10.1111/ajt.13355. Epub 2015 Jun 16.

DOI:10.1111/ajt.13355
PMID:26080906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4744749/
Abstract

A calculated panel reactive antibody (cPRA) estimates the percentage of donors with unacceptable antigens (UA) for a recipient. cPRA may be underestimated in transplant candidates with UA to DQA, DPA, and DPB if these are not included in the calculation program. To serve the National Canadian Transplant Programs, a cPRA calculator was developed with complete molecular typing for all donors at HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1, and DPB1, all resolved to serologic equivalents. The prevalence of UA at DQA, DPA and DPB was evaluated in a sensitized regional population. The impact of adding these additional UA to cPRA was calculated alone and in combination, and compared to the baseline cPRA for UA at A, B, C, DR, DR51/52/53, and DQ. Of 740 sensitized transplant candidates, 18% of total and 32% with cPRA≥95% had DQA UA. Twenty-seven percent of total and 54% with cPRA≥95% had DPB UA. Of 280/740 subjects with these UA, 36/280 (13%) had cPRA increase of >20% when they were included, 7% increased cPRA to ≥80% and 6% to ≥95%. Inclusion of DQA, DPA, and DPB UA in Canadian cPRA calculations improves the accuracy of cPRA where these are relevant in allocation.

摘要

计算得出的群体反应性抗体(cPRA)可估算出受体不可接受抗原(UA)的供体百分比。对于存在针对DQA、DPA和DPB的UA的移植候选者,如果这些抗原未包含在计算程序中,cPRA可能会被低估。为服务于加拿大全国移植项目,开发了一种cPRA计算器,对所有供体的HLA - A、B、C、DRB1、DRB3/4/5、DQA1、DQB1、DPA1和DPB1进行完整的分子分型,所有结果均转化为血清学等效值。在一个致敏的区域人群中评估了DQA、DPA和DPB处UA的流行率。单独及联合计算添加这些额外UA对cPRA的影响,并与A、B、C、DR、DR51/52/53和DQ处UA的基线cPRA进行比较。在740名致敏移植候选者中,总计18%且cPRA≥95%的患者存在DQA UA。总计27%且cPRA≥95%的患者存在DPB UA。在740名中有280名存在这些UA的受试者中,当纳入这些抗原时,280名中有36名(13%)的cPRA增加超过20%,7%的cPRA增加到≥80%,6%增加到≥95%。在加拿大cPRA计算中纳入DQA、DPA和DPB UA可提高cPRA在分配中相关情况下的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/0d92362f1adc/AJT-15-3194-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/b08a85cf0b37/AJT-15-3194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/0f64d1a16903/AJT-15-3194-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/6bde578144ec/AJT-15-3194-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/809eea292b1b/AJT-15-3194-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/0d92362f1adc/AJT-15-3194-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/b08a85cf0b37/AJT-15-3194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/0f64d1a16903/AJT-15-3194-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/6bde578144ec/AJT-15-3194-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/809eea292b1b/AJT-15-3194-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceda/4744749/0d92362f1adc/AJT-15-3194-g005.jpg

相似文献

1
cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.在加拿大cPRA计算器中,cPRA随DQA、DPA和DPB不可接受抗原增加而升高。
Am J Transplant. 2015 Dec;15(12):3194-201. doi: 10.1111/ajt.13355. Epub 2015 Jun 16.
2
Application of calculated panel reactive antibody using HLA frequencies in Koreans.应用 HLA 频率计算 panel reactive antibody 在韩国人中的应用。
Ann Lab Med. 2012 Jan;32(1):66-72. doi: 10.3343/alm.2012.32.1.66. Epub 2011 Dec 20.
3
Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.建立计算性群体反应抗体及其在改善台湾肾脏分配策略中的潜在益处。
J Formos Med Assoc. 2017 Dec;116(12):956-963. doi: 10.1016/j.jfma.2017.09.008. Epub 2017 Oct 14.
4
HLA-DQ barrier: effects on cPRA calculations.HLA-DQ 屏障:对 cPRA 计算的影响。
Transplantation. 2013 Dec 27;96(12):1065-72. doi: 10.1097/TP.0b013e3182a452a5.
5
Refining cPRA calculation to improve HLA compatibility assessment in organ transplantation: A detailed picture of the Paris waiting list.优化 cPRA 计算以改善器官移植中的 HLA 相容性评估:巴黎等待名单的详细情况。
HLA. 2024 Sep;104(3):e15675. doi: 10.1111/tan.15675.
6
Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.利用科学技术进步提高肾脏分配政策的公平性。
Am J Transplant. 2017 Dec;17(12):3149-3158. doi: 10.1111/ajt.14389. Epub 2017 Jul 17.
7
Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.在肾移植中特异性“等位基因内”和“同种异型抗原内”人类白细胞抗原同种抗体。
Hum Immunol. 2010 Sep;71(9):857-60. doi: 10.1016/j.humimm.2010.05.018. Epub 2010 May 25.
8
Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.使用计算性群体反应性抗体软件得出的土耳其人群中致敏患者的校正群体反应性抗体阳性率。
Transplant Proc. 2017 Apr;49(3):445-447. doi: 10.1016/j.transproceed.2017.01.032.
9
Evaluation of Changes in New Calculated Panel Reactive Antibody Adopting HLA-Cw, DR51/52/53, and DQ Antigens in Koreans.采用HLA-Cw、DR51/52/53和DQ抗原评估韩国人新计算的群体反应性抗体的变化。
Transplant Proc. 2016 Apr;48(3):766-9. doi: 10.1016/j.transproceed.2015.12.124.
10
Portuguese calculated panel reactive antibodies online estimator.葡萄牙语计算的面板反应性抗体在线估算器。
HLA. 2019 Jun;93(6):445-450. doi: 10.1111/tan.13516. Epub 2019 Mar 21.

引用本文的文献

1
Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8/DR4: results of a single-centre retrospective cohort in Canada.1型糖尿病的胰岛移植结果及HLA-DQ8/DR4移植:加拿大一项单中心回顾性队列研究结果
EClinicalMedicine. 2023 Dec 13;67:102333. doi: 10.1016/j.eclinm.2023.102333. eCollection 2024 Jan.
2
Waiting time for kidney transplantation based on calculated panel reactive antibodies: experience of a southern Brazilian center.基于计算的 panel reactive antibodies 的肾移植等待时间:巴西南部中心的经验。
J Bras Nefrol. 2024 Jan-Mar;46(1):79-84. doi: 10.1590/2175-8239-JBN-2022-0132en.
3

本文引用的文献

1
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?对于致敏移植候选者,HLA 错配的可接受性是否应在高分辨率水平而不是抗原水平上确定?
Am J Transplant. 2015 Apr;15(4):923-30. doi: 10.1111/ajt.13167. Epub 2015 Mar 16.
2
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients.器官获取与移植网络(OPTN)新的肾脏分配政策:高敏患者中存在获取不平等的可能性。
Am J Transplant. 2015 Jan;15(1):284-5. doi: 10.1111/ajt.13061. Epub 2014 Nov 17.
3
The Canadian kidney paired donation program: a national program to increase living donor transplantation.
Development of a calculated panel reactive antibody calculator for the United Arab Emirates: a proof of concept study.
阿联酋计算性 panel reactive antibody 计算器的开发:概念验证研究。
Sci Rep. 2023 May 25;13(1):8468. doi: 10.1038/s41598-023-34860-y.
4
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.ABO 调整后的计算群体反应性抗体(cPRA):肾移植免疫相容性的统一指标。
Am J Transplant. 2022 Dec;22(12):3093-3100. doi: 10.1111/ajt.17175. Epub 2022 Aug 30.
5
Immunological considerations-HLA matching and management of high immunological risk recipients.免疫学考量——HLA配型与高免疫风险受者的管理
Indian J Thorac Cardiovasc Surg. 2022 Jul;38(Suppl 2):248-259. doi: 10.1007/s12055-021-01201-5. Epub 2021 Jul 29.
6
HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates.肾移植候选者中的HLA纯合性与致敏可能性
Transplant Direct. 2022 Apr 7;8(5):e1312. doi: 10.1097/TXD.0000000000001312. eCollection 2022 May.
7
Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.通过 Luminex HLA MHC 类 I 单抗原珠测试鉴定假阳性的重现模式。
Hum Immunol. 2020 Feb-Mar;81(2-3):73-78. doi: 10.1016/j.humimm.2019.12.006. Epub 2020 Jan 6.
8
Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification.开发一种具有本地频率的计算性群体反应性抗体网络服务,用于血小板输注无效风险分层。
J Pathol Inform. 2019 Aug 1;10:26. doi: 10.4103/jpi.jpi_29_19. eCollection 2019.
9
Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness.西班牙群体反应性抗体计算器的评估及潜在用途
Front Immunol. 2017 May 11;8:540. doi: 10.3389/fimmu.2017.00540. eCollection 2017.
10
Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.肾移植排斥反应管理中的范式转变:从基于方案的治疗向精准医疗时代演进。
Can J Kidney Health Dis. 2017 Jan 23;4:2054358116688227. doi: 10.1177/2054358116688227. eCollection 2017.
加拿大肾脏配对捐赠计划:一项增加活体供体移植的全国性计划。
Transplantation. 2015 May;99(5):985-90. doi: 10.1097/TP.0000000000000455.
4
First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry.HLA表位登记处记录的HLA-DR、HLA-DQ和HLA-DP表位抗体验证的首次报告。
Hum Immunol. 2014 Nov;75(11):1097-103. doi: 10.1016/j.humimm.2014.09.012. Epub 2014 Oct 13.
5
Kidney paired donation: principles, protocols and programs.肾配对捐赠:原则、方案与项目
Nephrol Dial Transplant. 2015 Aug;30(8):1276-85. doi: 10.1093/ndt/gfu309. Epub 2014 Oct 7.
6
Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.中心定义的不可接受的 HLA 抗原促进了多中心肾脏交换项目中致敏患者的移植。
Am J Transplant. 2014 Jul;14(7):1592-8. doi: 10.1111/ajt.12734. Epub 2014 Jun 16.
7
New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.美国已故捐赠者肾脏的新国家分配政策及其对患者治疗结果的可能影响。
J Am Soc Nephrol. 2014 Aug;25(8):1842-8. doi: 10.1681/ASN.2013070784. Epub 2014 May 15.
8
HLA-DQ barrier: effects on cPRA calculations.HLA-DQ 屏障:对 cPRA 计算的影响。
Transplantation. 2013 Dec 27;96(12):1065-72. doi: 10.1097/TP.0b013e3182a452a5.
9
The DQ barrier: improving organ allocation equity using HLA-DQ information.DQ 屏障:利用 HLA-DQ 信息改善器官分配公平性。
Transplantation. 2013 Feb 27;95(4):635-40. doi: 10.1097/TP.0b013e318277b30b.
10
Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program.心脏移植中的高敏患者:加拿大优先器官共享计划的早期结果。
J Heart Lung Transplant. 2012 Jul;31(7):780-2. doi: 10.1016/j.healun.2012.02.017. Epub 2012 Mar 21.